Related Experiment Video

Updated: Oct 18, 2026

Use of Hematopoietic Stem Cell Transplantation to Assess the Origin of Myelodysplastic Syndrome
06:39

Use of Hematopoietic Stem Cell Transplantation to Assess the Origin of Myelodysplastic Syndrome

Published on: October 3, 2018

Guillain-Barré syndrome after autologous peripheral blood stem cell transplantation for CML

J J Janssen, G Tissingh, G J Ossenkoppele

    European Journal of Haematology
    |December 2, 1999
    PubMed
    Abstract

    No abstract available in PubMed .

    More Related Videos

    Busulfan as a Myelosuppressive Agent for Generating Stable High-level Bone Marrow Chimerism in Mice
    11:25

    Busulfan as a Myelosuppressive Agent for Generating Stable High-level Bone Marrow Chimerism in Mice

    Published on: April 1, 2015

    Related Experiment Videos

    Last Updated: Oct 18, 2026

    Use of Hematopoietic Stem Cell Transplantation to Assess the Origin of Myelodysplastic Syndrome
    06:39

    Use of Hematopoietic Stem Cell Transplantation to Assess the Origin of Myelodysplastic Syndrome

    Published on: October 3, 2018

    Busulfan as a Myelosuppressive Agent for Generating Stable High-level Bone Marrow Chimerism in Mice
    11:25

    Busulfan as a Myelosuppressive Agent for Generating Stable High-level Bone Marrow Chimerism in Mice

    Published on: April 1, 2015

    Related Concept Videos

    Bone Marrow Sampling and Transplants01:22

    Bone Marrow Sampling and Transplants

    Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
    The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy the...

    Articles linked to this work by shared authors, journal, and citation graph.

    Determinants of lenalidomide response with or without erythropoiesis-stimulating agents in myelodysplastic syndromes: the HOVON89 trial.

    Leukemia·2024

    Steps towards implementation of protocolized dose reduction of adalimumab, etanercept and ustekinumab for psoriasis in daily practice.

    The Journal of dermatological treatment·2023

    Addition of the nuclear export inhibitor selinexor to standard intensive treatment for elderly patients with acute myeloid leukemia and high risk myelodysplastic syndrome.

    Leukemia·2022

    Evaluating ivosidenib for the treatment of acute myeloid leukemia.

    Expert opinion on pharmacotherapy·2020

    Correction: Lenalidomide added to standard intensive treatment for older patients with AML and high-risk MDS.

    Leukemia·2020

    Lenalidomide added to standard intensive treatment for older patients with AML and high-risk MDS.

    Leukemia·2020

    Partial Red Cell Exchange in the Secondary Prevention of Stroke in Sickle Cell Disease: A Prospective Study.

    European journal of haematology·2026

    Chimeric Antigen Receptor T-Cell Therapy in T Cell/Histiocyte-Rich Large B-Cell Lymphoma: A Systematic Review and Meta-Analysis.

    European journal of haematology·2026

    Association Between the Time of Day of Post-Transplant Cyclophosphamide Administration and Haemorrhagic Cystitis After Allogeneic Haematopoietic Stem Cell Transplantation.

    European journal of haematology·2026

    Elevated Risks for Depression and Anxiety Following Diagnosis of Multiple Myeloma.

    European journal of haematology·2026

    BCMA-Targeted Immunotherapy in Early Relapsed/Refractory Multiple Myeloma: Mechanisms, Clinical Evidence, and Practical Management.

    European journal of haematology·2026

    Beyond Extranodal Site Count: Clinical and Anatomical Characterization of Primary Multifocal Extranodal Diffuse Large B-Cell Lymphoma.

    European journal of haematology·2026

    Thyroid and Parathyroid Dysfunction Following Larynx-Trachea-Thyroid-Parathyroid Allotransplantation.

    The Laryngoscope·2026

    Pre-transplant bone marrow lymphocyte subsets predict outcome after allogeneic stem cell transplantation.

    Frontiers in immunology·2026

    Posttransplant Tubulointerstitial Nephritis in Kidney Recipients: From Bacteria to BK Virus: A 24-Year Single-Center Analysis of Etiology, Timing, and Graft Survival.

    Experimental and clinical transplantation : official journal of the Middle East Society for Organ Transplantation·2026

    Molecular HLA matching in kidney transplantation: the emerging role of eplet mismatch analysis.

    Expert review of clinical immunology·2026

    Immunosuppression and Long-term Survival After Single Living-donor Lobar Lung Transplantation From the Same Donor as Prior Hematopoietic Stem Cell Transplantation: An All-Japan Study.

    Transplantation·2026

    Association of intraoperative mitoxantrone hydrochloride injection with incidental parathyroidectomy and parathyroid autotransplantation during gasless unilateral axillary endoscopic thyroidectomy: a propensity score-matched retrospective cohort study.

    Gland surgery·2026
    See all related articles
    JoVE
    x logofacebook logolinkedin logoyoutube logo
    ABOUT JoVE
    OverviewLeadershipBlogJoVE Help Center
    AUTHORS
    Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
    LIBRARIANS
    TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
    RESEARCH
    JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
    EDUCATION
    JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
    Terms & Conditions of Use
    Privacy Policy
    Policies
    Jove
    Visualize
    Contact Us